Navigation Links
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Date:8/19/2007

d a two-stage min-max design in which if there were at least nine responses in the first 42 patients, the trial was to continue to the second stage. On January 25, 2007, the Company announced that there had been at least nine remissions in the first stage and that the trial would therefore continue. Eighty-five patients were enrolled in order to ensure that at least 77 would be eligible for the trial and included in the full analysis set. At least 22 responses in 77 patients are required to confirm the 35% target response rate with 95% confidence. If the full analysis set includes all 85 patients, then at least 24 responses are required for confirmation of the target response rate.

Dr. Dan DeAngelo, Assistant Professor at Harvard Medical School and the Dana Farber Cancer Institute and an investigator on the trial commented, "The treatment of elderly patients with poor-risk AML represents a significant unmet medical need in clinical oncology, and it is important that we find new effective treatment options. Agents such as Cloretazine(R) (VNP40101M) have the potential to address this need."

Dr. Gary Schiller, Professor of Medicine at the UCLA Geffen School of Medicine and an investigator on the trial added, "This was a very important study for older AML patients treated here at UCLA. As a single agent therapy administered over 30 to 60 minutes, Cloretazine(R) (VNP40101M) is clearly an active agent with the potential to play an important role in the treatment of this difficult population."

On August 8, 2007, the Company announced that certain sites on the trial would remain open and continue to accrue patients to an ECG sub-study. Recent FDA/ICH guidance recommends that an electrocardiographic evaluation (QT/QTc) study be included in the clinical development of all new drugs. Normally these studies are conducted in healthy subjects so that disease factors/co- morbidities do not confound the results. As Cloretazine(R) (VNP40101M) is a cytotoxic agent w
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  The efficacy of ... highlighted in a recently published study 1 of ... prevention research team, including Curtis Donskey , M.D.  ... run for the same length of time from the ... (PU-UV) unit.  The results showed surprisingly low pathogen kill ...
(Date:3/31/2015)... , March 31, 2015  Frequentz Inc., a global ... a white paper to help the pharmaceutical industry understand ... Supply Chain Security Act (DSCSA). The white paper, "From ... the GS1 EPCIS Standard(s) and Implementation Plan ... the product tracing requirements that need to occur between ...
(Date:3/31/2015)... March 31, 2015  Dr. Renu Razdan of ... World Orphan Drug Congress in April to discuss the latest, ... process and orphan drugs below: India,s ... the Ministry of Health that if a new drug is ... be obtained in India with waiver ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2
(Date:3/31/2015)... 31, 2015 Over the last several ... Water Blackout and conducted a survey to learn just ... , For additional information about Shallow Water Blackout Prevention, ... To read the educational articles please go to the ... many useful comments and personal stories about people’s firsthand ...
(Date:3/31/2015)... The Oliver Law Group, who ... notes that filings for testosterone lawsuits that allege ... complications associated with testosterone therapy products such as ... steady pace. The website for the U.S. District ... lawsuits have been centralized, shows 1,291 testosterone lawsuits ...
(Date:3/31/2015)... MN (PRWEB) March 31, 2015 Burns Engineering ... Temperature Sensors for the Food & Beverage, Pharmaceutical and ... #74 , are ASME-BPE compliant and are now available as ... up and running. , The S01 and S03 ... with Hygenic Ferrule process connections used in process lines 1/4” ...
(Date:3/31/2015)... GA (PRWEB) March 31, 2015 When SIGVARIS ... the company’s most successful product launch to date. Women immediately ... SIGVARIS is giving women another reason to love EVERSHEER with ... time for spring. , Lavender mist pairs perfectly with ... and neutral outfits. For women looking to add a hint ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 A' Design Award ... Food Feeder Plus by Justin Cheung has been announced as ... Baby, Kids' and Children's Products Design Competition Category. , ... of the awarded Baby Products project Food Feeder Plus demonstrated ... alone, but also means more independence for the parents. Babies ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group 2Health News:Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group 3Health News:Burns Engineering Now Offers 3-Day Quick Ship on Sanitary RTDs and Thermocouples 2Health News:Put Spring in Your Step with SIGVARIS’ Top Selling Sheer Hosiery Compression Therapy Brand 2Health News:Justin Cheung wins Golden in A' International Baby Products Design Awards 2
... , BARCELONA, Spain , ... the availability of their new Bluegiga eHealth Access Point,based ... can be,utilised in various health and medical applications. The ... Point will be,implemented in Japan by Alive-inc ...
... ... opportunity to spend a week meditating, learning, and exploring the secrets of true success and ... ... 2010 -- This March 21–27 the Chopra Center for Wellbeing is coming to Marco Island, ...
... Feb. 16 United American Healthcare Corporation (Nasdaq: UAHC ... ended Dec. 31, 2009 .   , Revenues for the ... , or 62 percent, compared with revenues of $4.5 million ... decline was primarily the result of the complete transfer of TennCare ...
... High blood pressure is the second leading cause of death ... attacks and almost half of heart failures each year even ... treat. In a new report, A Population-Based Policy and Systems ... Medicine explores the question of how we can better reduce ...
... , ... with Tips on Breastfeeding and Basic Hygiene to Help Save Babies, Lives During Upcoming ... ... the upcoming rainy season in Haiti, after the devastating earthquake in January, Save the ...
... Procrit, similar medicines have been tied to strokes, tumor progression ... News) -- U.S. federal health authorities on Tuesday rolled out ... similar anemia drugs by people with cancer. , These medicines ... for blood transfusions and improve quality of life -- have ...
Cached Medicine News:Health News:Bluegiga Expands to Health and Medical Market With the New Bluegiga eHealth Access Point 2Health News:Bluegiga Expands to Health and Medical Market With the New Bluegiga eHealth Access Point 3Health News:Tired of Snow, Sleet, and Stress? Join Deepak Chopra for a Week-Long Meditation Retreat this March in Florida's Warm Sunshine 2Health News:Tired of Snow, Sleet, and Stress? Join Deepak Chopra for a Week-Long Meditation Retreat this March in Florida's Warm Sunshine 3Health News:United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results 6Health News:United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results 7Health News:United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results 8Health News:Save the Children Provides Songs with Lifesaving Health and Nutrition Advice to Haitian Radio Stations 2Health News:Save the Children Provides Songs with Lifesaving Health and Nutrition Advice to Haitian Radio Stations 3Health News:FDA Tightens Controls on Anemia Drugs 2Health News:FDA Tightens Controls on Anemia Drugs 3
The most advanced retinal cameras for fluorescein, color and ICG angiography with full digital imaging capability....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
Medicine Products: